Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSMUSG00000023852.7 | Chd1 |
Pml
|
ENSMUSG00000036986.10 | Pml |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Chd1 | chr17_15709158_15709361 | 4241 | 0.236228 | 0.34 | 7.2e-03 | Click! |
Chd1 | chr17_15708767_15708918 | 3824 | 0.244350 | 0.29 | 2.7e-02 | Click! |
Chd1 | chr17_15705036_15705405 | 202 | 0.946506 | 0.25 | 5.1e-02 | Click! |
Chd1 | chr17_15702797_15702948 | 2095 | 0.330419 | -0.21 | 1.1e-01 | Click! |
Chd1 | chr17_15707788_15708369 | 3060 | 0.267879 | 0.14 | 2.7e-01 | Click! |
Pml | chr9_58249833_58250219 | 240 | 0.877219 | -0.39 | 1.9e-03 | Click! |
Pml | chr9_58245377_58245567 | 4151 | 0.138293 | 0.30 | 2.1e-02 | Click! |
Pml | chr9_58246028_58246254 | 3482 | 0.149023 | 0.25 | 5.7e-02 | Click! |
Pml | chr9_58249301_58249714 | 116 | 0.941010 | -0.20 | 1.2e-01 | Click! |
Pml | chr9_58245185_58245336 | 4363 | 0.135784 | 0.12 | 3.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_89879614_89881129 | 40.44 |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
29537 |
0.16 |
chr19_6497246_6498663 | 16.97 |
Nrxn2 |
neurexin II |
119 |
0.94 |
chr19_7421074_7423945 | 15.09 |
Mir6991 |
microRNA 6991 |
64 |
0.94 |
chr7_126823319_126824529 | 14.50 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr2_153528339_153529939 | 14.22 |
Nol4l |
nucleolar protein 4-like |
832 |
0.63 |
chr2_158614356_158617139 | 13.23 |
Gm14205 |
predicted gene 14205 |
3927 |
0.13 |
chr5_121711876_121713175 | 12.89 |
Atxn2 |
ataxin 2 |
444 |
0.71 |
chr11_96282910_96285155 | 12.48 |
Hoxb8 |
homeobox B8 |
1307 |
0.19 |
chr4_133752701_133753843 | 12.27 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
339 |
0.85 |
chr9_22050521_22051976 | 12.13 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr11_96343236_96346574 | 11.90 |
Hoxb3 |
homeobox B3 |
1136 |
0.24 |
chr10_7955099_7956159 | 11.73 |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
264 |
0.93 |
chr11_75165245_75169157 | 11.49 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr2_164967685_164969910 | 11.40 |
Slc12a5 |
solute carrier family 12, member 5 |
516 |
0.7 |
chr3_94478073_94479450 | 11.18 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr3_88214322_88216234 | 10.31 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr13_55211864_55213064 | 10.22 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
78 |
0.96 |
chr7_19082814_19086200 | 10.12 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr4_99655774_99658132 | 10.02 |
Foxd3 |
forkhead box D3 |
654 |
0.43 |
chr1_181210767_181211914 | 9.87 |
Wdr26 |
WD repeat domain 26 |
86 |
0.96 |
chr7_44350602_44354420 | 9.86 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr2_70561988_70564432 | 9.79 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr7_46396141_46398423 | 9.63 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
366 |
0.84 |
chr15_74516560_74519631 | 9.44 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
1264 |
0.47 |
chr15_76517568_76519917 | 9.42 |
Scrt1 |
scratch family zinc finger 1 |
3160 |
0.09 |
chr7_25249035_25250700 | 9.37 |
Erf |
Ets2 repressor factor |
863 |
0.36 |
chr5_139543263_139545139 | 9.25 |
Uncx |
UNC homeobox |
303 |
0.89 |
chr10_127059291_127060488 | 9.25 |
Marchf9 |
membrane associated ring-CH-type finger 9 |
295 |
0.74 |
chr8_84703616_84705950 | 9.16 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr19_6418703_6419936 | 9.09 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr7_79498955_79500626 | 9.02 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr2_33370460_33371420 | 8.75 |
Ralgps1 |
Ral GEF with PH domain and SH3 binding motif 1 |
489 |
0.77 |
chr9_63144078_63146888 | 8.66 |
Skor1 |
SKI family transcriptional corepressor 1 |
1497 |
0.38 |
chr2_158610228_158611991 | 8.61 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr5_106453173_106456366 | 8.54 |
Barhl2 |
BarH like homeobox 2 |
3397 |
0.22 |
chr10_81429822_81431152 | 8.45 |
Nfic |
nuclear factor I/C |
518 |
0.52 |
chr4_16162887_16164474 | 8.34 |
Ripk2 |
receptor (TNFRSF)-interacting serine-threonine kinase 2 |
33 |
0.88 |
chr11_102296460_102297137 | 8.21 |
Atxn7l3 |
ataxin 7-like 3 |
167 |
0.9 |
chr3_92080511_92081802 | 8.16 |
Lor |
loricrin |
1986 |
0.2 |
chr15_96286968_96288193 | 8.08 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
7 |
0.98 |
chr12_100199623_100200956 | 8.02 |
Calm1 |
calmodulin 1 |
145 |
0.94 |
chr2_152081612_152083149 | 7.97 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr4_140701540_140702640 | 7.94 |
Rcc2 |
regulator of chromosome condensation 2 |
617 |
0.61 |
chr5_22344079_22345341 | 7.88 |
Reln |
reelin |
8 |
0.97 |
chr7_45047563_45050465 | 7.83 |
Prr12 |
proline rich 12 |
3867 |
0.07 |
chr2_153345876_153347096 | 7.82 |
2500004C02Rik |
RIKEN cDNA 2500004C02 gene |
413 |
0.6 |
chr19_29805055_29806432 | 7.80 |
9930021J03Rik |
RIKEN cDNA 9930021J03 gene |
236 |
0.85 |
chr5_37241461_37244349 | 7.77 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chrX_137118132_137120673 | 7.68 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr9_106147912_106149765 | 7.68 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr11_60175569_60177218 | 7.64 |
Rai1 |
retinoic acid induced 1 |
514 |
0.7 |
chrX_48341385_48342464 | 7.60 |
Bcorl1 |
BCL6 co-repressor-like 1 |
137 |
0.95 |
chrX_12087097_12088660 | 7.55 |
Bcor |
BCL6 interacting corepressor |
7325 |
0.28 |
chr11_97150575_97151770 | 7.52 |
Tbkbp1 |
TBK1 binding protein 1 |
136 |
0.91 |
chr6_108659051_108660392 | 7.48 |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
908 |
0.41 |
chr12_86881882_86884741 | 7.47 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
1487 |
0.4 |
chr4_109475656_109476957 | 7.44 |
Rnf11 |
ring finger protein 11 |
369 |
0.86 |
chr1_13372873_13373994 | 7.35 |
Ncoa2 |
nuclear receptor coactivator 2 |
596 |
0.62 |
chr5_125056018_125058841 | 7.34 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr2_19657796_19658995 | 7.32 |
Otud1 |
OTU domain containing 1 |
643 |
0.61 |
chr2_118901607_118902784 | 7.30 |
Bahd1 |
bromo adjacent homology domain containing 1 |
742 |
0.58 |
chr12_76709422_76710754 | 7.26 |
Sptb |
spectrin beta, erythrocytic |
65 |
0.98 |
chr8_84741754_84745977 | 7.21 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
20858 |
0.09 |
chr2_174330185_174331360 | 7.21 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
485 |
0.75 |
chrX_170674573_170675954 | 7.13 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr4_22487396_22488284 | 7.09 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
526 |
0.73 |
chr10_81481482_81482676 | 7.05 |
Celf5 |
CUGBP, Elav-like family member 5 |
593 |
0.47 |
chr6_113890285_113891668 | 7.04 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
394 |
0.85 |
chr6_120037117_120038604 | 7.03 |
Wnk1 |
WNK lysine deficient protein kinase 1 |
201 |
0.93 |
chr2_157914223_157915670 | 6.99 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr1_64736856_64737984 | 6.98 |
Fzd5 |
frizzled class receptor 5 |
329 |
0.8 |
chr7_25071787_25073006 | 6.98 |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
50 |
0.66 |
chr14_21499031_21500426 | 6.98 |
Kat6b |
K(lysine) acetyltransferase 6B |
42 |
0.98 |
chr4_151994846_151996125 | 6.95 |
Phf13 |
PHD finger protein 13 |
773 |
0.47 |
chr5_64159427_64160996 | 6.88 |
Tbc1d1 |
TBC1 domain family, member 1 |
0 |
0.97 |
chr14_55114527_55116659 | 6.85 |
Jph4 |
junctophilin 4 |
41 |
0.94 |
chr8_122677313_122678795 | 6.78 |
Cbfa2t3 |
CBFA2/RUNX1 translocation partner 3 |
18 |
0.96 |
chr5_88720866_88722164 | 6.78 |
Mob1b |
MOB kinase activator 1B |
538 |
0.73 |
chr13_29983771_29984979 | 6.68 |
E2f3 |
E2F transcription factor 3 |
16 |
0.98 |
chr1_72536044_72537425 | 6.62 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
196 |
0.95 |
chr1_178336630_178337657 | 6.61 |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
585 |
0.59 |
chr7_25004827_25006284 | 6.61 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr11_4947036_4948194 | 6.57 |
Nefh |
neurofilament, heavy polypeptide |
449 |
0.76 |
chr7_44441951_44442938 | 6.55 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr1_134560277_134561609 | 6.54 |
Kdm5b |
lysine (K)-specific demethylase 5B |
736 |
0.56 |
chr6_114282516_114283979 | 6.49 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr6_39724228_39725649 | 6.46 |
Braf |
Braf transforming gene |
255 |
0.93 |
chr1_92849002_92850443 | 6.45 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr8_84799222_84800097 | 6.44 |
Nfix |
nuclear factor I/X |
365 |
0.75 |
chr1_119421189_119422437 | 6.42 |
Inhbb |
inhibin beta-B |
435 |
0.83 |
chr11_109472975_109474195 | 6.42 |
Slc16a6 |
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
13 |
0.73 |
chr2_146221972_146223699 | 6.38 |
Insm1 |
insulinoma-associated 1 |
914 |
0.56 |
chrX_36328454_36330353 | 6.35 |
Lonrf3 |
LON peptidase N-terminal domain and ring finger 3 |
187 |
0.93 |
chr10_120978049_120979298 | 6.33 |
Lemd3 |
LEM domain containing 3 |
659 |
0.62 |
chrX_7638310_7639997 | 6.33 |
Syp |
synaptophysin |
152 |
0.88 |
chr4_140245362_140247262 | 6.24 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr5_53212692_53214024 | 6.22 |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
43 |
0.98 |
chr6_91409540_91411888 | 6.21 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
649 |
0.42 |
chr10_127078876_127080327 | 6.18 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
694 |
0.42 |
chr2_180892979_180894605 | 6.17 |
Mir124a-3 |
microRNA 124a-3 |
248 |
0.53 |
chr4_87432122_87432530 | 6.16 |
Gm23154 |
predicted gene, 23154 |
54 |
0.99 |
chr17_28040550_28042470 | 6.15 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
227 |
0.89 |
chr6_122339086_122340438 | 6.12 |
Phc1 |
polyhomeotic 1 |
54 |
0.96 |
chr11_118568846_118570341 | 6.12 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
317 |
0.91 |
chr11_69836688_69838020 | 6.12 |
Nlgn2 |
neuroligin 2 |
430 |
0.51 |
chr1_42697532_42698715 | 6.07 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
2355 |
0.2 |
chr7_44336079_44337576 | 6.07 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr5_90364932_90366132 | 5.99 |
Ankrd17 |
ankyrin repeat domain 17 |
653 |
0.56 |
chr11_100758699_100760184 | 5.99 |
Kcnh4 |
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
299 |
0.8 |
chrX_77432774_77434116 | 5.95 |
Gm5937 |
predicted gene 5937 |
23141 |
0.22 |
chr7_127026886_127027456 | 5.92 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
134 |
0.83 |
chr11_94211525_94212733 | 5.88 |
Tob1 |
transducer of ErbB-2.1 |
675 |
0.69 |
chr19_7416824_7418011 | 5.84 |
2700081O15Rik |
RIKEN cDNA 2700081O15 gene |
208 |
0.88 |
chrX_142681454_142682792 | 5.84 |
Tmem164 |
transmembrane protein 164 |
397 |
0.86 |
chr11_94991074_94992710 | 5.79 |
Ppp1r9b |
protein phosphatase 1, regulatory subunit 9B |
857 |
0.44 |
chr5_115542473_115545179 | 5.78 |
Pxn |
paxillin |
121 |
0.92 |
chr16_11253207_11254246 | 5.77 |
Gspt1 |
G1 to S phase transition 1 |
483 |
0.54 |
chr5_139546076_139547826 | 5.76 |
Uncx |
UNC homeobox |
3053 |
0.23 |
chr10_127380681_127381499 | 5.72 |
R3hdm2 |
R3H domain containing 2 |
291 |
0.81 |
chr9_74861883_74864045 | 5.70 |
Onecut1 |
one cut domain, family member 1 |
1043 |
0.45 |
chr5_123147784_123150032 | 5.69 |
Setd1b |
SET domain containing 1B |
5951 |
0.08 |
chr9_94538014_94538635 | 5.69 |
Dipk2a |
divergent protein kinase domain 2A |
243 |
0.94 |
chrX_12078415_12080447 | 5.62 |
Bcor |
BCL6 interacting corepressor |
1122 |
0.62 |
chrX_51017522_51018698 | 5.62 |
Rap2c |
RAP2C, member of RAS oncogene family |
92 |
0.98 |
chr9_91363965_91365514 | 5.62 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1029 |
0.35 |
chr7_80197844_80199539 | 5.60 |
Sema4b |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
155 |
0.91 |
chr15_89499362_89500540 | 5.60 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
172 |
0.89 |
chr2_44926970_44927284 | 5.58 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
22 |
0.99 |
chr9_44486015_44488913 | 5.56 |
Bcl9l |
B cell CLL/lymphoma 9-like |
217 |
0.81 |
chr15_36792592_36793493 | 5.55 |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
168 |
0.94 |
chr4_129120600_129121975 | 5.55 |
Hpca |
hippocalcin |
4 |
0.96 |
chr3_84814694_84815805 | 5.54 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
19 |
0.99 |
chr6_127151640_127154010 | 5.53 |
Ccnd2 |
cyclin D2 |
632 |
0.57 |
chr8_121730928_121732115 | 5.53 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr3_144204375_144205487 | 5.53 |
Lmo4 |
LIM domain only 4 |
249 |
0.93 |
chr15_72546044_72547992 | 5.52 |
Kcnk9 |
potassium channel, subfamily K, member 9 |
678 |
0.75 |
chr1_82290989_82292162 | 5.51 |
Irs1 |
insulin receptor substrate 1 |
159 |
0.96 |
chr19_6398611_6400187 | 5.51 |
Rasgrp2 |
RAS, guanyl releasing protein 2 |
57 |
0.93 |
chr7_25149860_25151724 | 5.47 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
1665 |
0.24 |
chr13_14063842_14064362 | 5.46 |
Arid4b |
AT rich interactive domain 4B (RBP1-like) |
47 |
0.91 |
chr2_31638722_31641540 | 5.44 |
Prdm12 |
PR domain containing 12 |
94 |
0.84 |
chr5_124248924_124250266 | 5.44 |
Pitpnm2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
144 |
0.92 |
chr9_44879862_44881307 | 5.43 |
Kmt2a |
lysine (K)-specific methyltransferase 2A |
282 |
0.76 |
chr11_119084981_119086150 | 5.42 |
Cbx4 |
chromobox 4 |
656 |
0.64 |
chr18_35771518_35772678 | 5.42 |
Ube2d2a |
ubiquitin-conjugating enzyme E2D 2A |
336 |
0.76 |
chr9_45905865_45906489 | 5.40 |
Rnf214 |
ring finger protein 214 |
196 |
0.62 |
chr6_83185720_83187846 | 5.40 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr11_98327227_98329144 | 5.39 |
Neurod2 |
neurogenic differentiation 2 |
1463 |
0.23 |
chr9_65346128_65347211 | 5.39 |
Pdcd7 |
programmed cell death 7 |
15 |
0.95 |
chr1_36068381_36069846 | 5.38 |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
713 |
0.61 |
chr8_79028577_79029976 | 5.38 |
Zfp827 |
zinc finger protein 827 |
689 |
0.71 |
chr17_28800544_28801564 | 5.35 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
36 |
0.9 |
chr3_136670117_136671072 | 5.35 |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
176 |
0.96 |
chr3_119782463_119783303 | 5.32 |
Ptbp2 |
polypyrimidine tract binding protein 2 |
351 |
0.85 |
chr11_97279431_97280550 | 5.30 |
Gm11592 |
predicted gene 11592 |
138 |
0.79 |
chr12_118300531_118301416 | 5.30 |
Sp4 |
trans-acting transcription factor 4 |
395 |
0.9 |
chr11_87357753_87359301 | 5.29 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
110 |
0.95 |
chr17_47877478_47879368 | 5.29 |
Foxp4 |
forkhead box P4 |
530 |
0.7 |
chr4_45529877_45530765 | 5.28 |
Shb |
src homology 2 domain-containing transforming protein B |
9 |
0.97 |
chr19_45230983_45235468 | 5.28 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr7_142094181_142095425 | 5.27 |
Dusp8 |
dual specificity phosphatase 8 |
469 |
0.54 |
chr2_52675553_52676663 | 5.23 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
35 |
0.98 |
chr9_63756717_63758746 | 5.23 |
Smad3 |
SMAD family member 3 |
263 |
0.93 |
chr5_123131617_123134965 | 5.23 |
Rhof |
ras homolog family member F (in filopodia) |
599 |
0.36 |
chr8_120537063_120538443 | 5.21 |
1700016A09Rik |
RIKEN cDNA 1700016A09 gene |
27 |
0.8 |
chr9_82974428_82975413 | 5.20 |
Phip |
pleckstrin homology domain interacting protein |
488 |
0.83 |
chr19_45782461_45783646 | 5.19 |
Oga |
O-GlcNAcase |
498 |
0.73 |
chr9_45432313_45432910 | 5.17 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
881 |
0.47 |
chr2_25290133_25293095 | 5.15 |
Grin1os |
glutamate receptor, ionotropic, NMDA1 (zeta 1), opposite strand |
394 |
0.57 |
chr7_30955780_30956931 | 5.15 |
Usf2 |
upstream transcription factor 2 |
116 |
0.75 |
chr17_3114961_3115824 | 5.14 |
Scaf8 |
SR-related CTD-associated factor 8 |
143 |
0.83 |
chr12_75595123_75596174 | 5.13 |
Ppp2r5e |
protein phosphatase 2, regulatory subunit B', epsilon |
552 |
0.76 |
chr18_35847749_35850271 | 5.12 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr11_102393440_102394677 | 5.11 |
Rundc3a |
RUN domain containing 3A |
655 |
0.52 |
chr7_127777424_127778134 | 5.10 |
Setd1a |
SET domain containing 1A |
84 |
0.92 |
chr7_30444318_30445408 | 5.10 |
Aplp1 |
amyloid beta (A4) precursor-like protein 1 |
267 |
0.76 |
chr15_38077521_38078812 | 5.10 |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
259 |
0.83 |
chr2_174329782_174330146 | 5.09 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
42 |
0.97 |
chr2_153031440_153032820 | 5.09 |
Xkr7 |
X-linked Kx blood group related 7 |
278 |
0.86 |
chr12_52504064_52505267 | 5.09 |
Arhgap5 |
Rho GTPase activating protein 5 |
323 |
0.89 |
chr15_78119178_78120215 | 5.08 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
10 |
0.83 |
chr15_76521966_76524145 | 5.08 |
Scrt1 |
scratch family zinc finger 1 |
556 |
0.5 |
chrX_20919797_20921410 | 5.08 |
Syn1 |
synapsin I |
315 |
0.81 |
chr10_42275609_42276721 | 5.08 |
Foxo3 |
forkhead box O3 |
531 |
0.84 |
chr8_122282024_122282411 | 5.07 |
Zfpm1 |
zinc finger protein, multitype 1 |
76 |
0.97 |
chr11_94472657_94474433 | 5.05 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
96 |
0.95 |
chr10_81426043_81427197 | 5.04 |
Nfic |
nuclear factor I/C |
494 |
0.54 |
chr6_38874889_38876891 | 5.04 |
Hipk2 |
homeodomain interacting protein kinase 2 |
33 |
0.9 |
chr7_127025097_127026155 | 5.03 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
494 |
0.48 |
chr5_43234069_43234894 | 5.03 |
Gm7854 |
predicted gene 7854 |
504 |
0.47 |
chr8_124792307_124794543 | 4.96 |
Trim67 |
tripartite motif-containing 67 |
333 |
0.82 |
chrX_9272247_9273630 | 4.95 |
Xk |
X-linked Kx blood group |
182 |
0.92 |
chr3_103790539_103791267 | 4.95 |
Hipk1 |
homeodomain interacting protein kinase 1 |
172 |
0.87 |
chr11_98795530_98796844 | 4.95 |
Msl1 |
male specific lethal 1 |
387 |
0.73 |
chr16_13447438_13448810 | 4.93 |
Mir193b |
microRNA 193b |
1399 |
0.31 |
chr7_25007823_25009791 | 4.93 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
2849 |
0.15 |
chr5_121220274_121221872 | 4.92 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
854 |
0.51 |
chr11_88068310_88069330 | 4.92 |
Vezf1 |
vascular endothelial zinc finger 1 |
541 |
0.65 |
chr6_140623766_140625086 | 4.91 |
Aebp2 |
AE binding protein 2 |
483 |
0.77 |
chr1_131525650_131527377 | 4.89 |
Srgap2 |
SLIT-ROBO Rho GTPase activating protein 2 |
834 |
0.47 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 17.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
4.3 | 17.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
4.0 | 8.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
3.8 | 11.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.6 | 10.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
3.6 | 14.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
3.5 | 10.6 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
3.4 | 26.9 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
3.3 | 13.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
3.3 | 43.2 | GO:0071625 | vocalization behavior(GO:0071625) |
3.2 | 9.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.2 | 9.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.1 | 9.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
3.0 | 14.8 | GO:0060789 | hair follicle placode formation(GO:0060789) |
2.9 | 8.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.8 | 8.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.8 | 2.8 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.8 | 22.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.8 | 11.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.7 | 2.7 | GO:1901660 | calcium ion export(GO:1901660) |
2.7 | 5.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.7 | 13.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.6 | 7.9 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
2.6 | 2.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.6 | 7.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.6 | 12.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
2.5 | 7.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
2.5 | 7.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.5 | 5.0 | GO:0045472 | response to ether(GO:0045472) |
2.5 | 12.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
2.4 | 2.4 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
2.4 | 7.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.4 | 2.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
2.4 | 14.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
2.4 | 7.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.3 | 7.0 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.3 | 6.9 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
2.3 | 6.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.3 | 9.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.2 | 6.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.2 | 6.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.2 | 6.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.2 | 8.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
2.2 | 4.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.2 | 8.7 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
2.1 | 6.4 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
2.1 | 38.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
2.1 | 6.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
2.1 | 12.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
2.1 | 10.3 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
2.0 | 12.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.0 | 2.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
2.0 | 6.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
2.0 | 14.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.0 | 8.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
2.0 | 5.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.0 | 5.9 | GO:1902075 | cellular response to salt(GO:1902075) |
1.9 | 5.8 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.9 | 3.9 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
1.9 | 5.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.9 | 15.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.9 | 5.7 | GO:0021586 | pons maturation(GO:0021586) |
1.9 | 7.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.8 | 5.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.8 | 5.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.8 | 3.6 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.8 | 3.6 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
1.8 | 8.8 | GO:0021764 | amygdala development(GO:0021764) |
1.8 | 12.3 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
1.8 | 10.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.8 | 3.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.8 | 7.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.7 | 8.7 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
1.7 | 5.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.7 | 10.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.7 | 16.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.7 | 3.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.7 | 3.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.7 | 1.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.7 | 15.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.7 | 8.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.7 | 11.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.6 | 3.3 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.6 | 4.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.6 | 11.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.6 | 3.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.6 | 1.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.6 | 3.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.6 | 3.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.6 | 23.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.5 | 4.6 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.5 | 4.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.5 | 6.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
1.5 | 10.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.5 | 4.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.5 | 3.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.5 | 4.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.5 | 4.4 | GO:0061010 | gall bladder development(GO:0061010) |
1.5 | 1.5 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
1.5 | 4.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.5 | 4.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.5 | 2.9 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.5 | 7.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.5 | 5.8 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.5 | 4.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.5 | 10.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.4 | 8.7 | GO:0001842 | neural fold formation(GO:0001842) |
1.4 | 1.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.4 | 4.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.4 | 14.4 | GO:0015816 | glycine transport(GO:0015816) |
1.4 | 4.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.4 | 21.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.4 | 7.1 | GO:0033483 | gas homeostasis(GO:0033483) |
1.4 | 2.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.4 | 1.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.4 | 4.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.4 | 4.2 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.4 | 2.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.4 | 18.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.4 | 8.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.4 | 1.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
1.4 | 2.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
1.4 | 4.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.4 | 4.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.4 | 5.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.4 | 5.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.4 | 6.8 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.3 | 4.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.3 | 5.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.3 | 1.3 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
1.3 | 8.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.3 | 12.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.3 | 6.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.3 | 1.3 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
1.3 | 5.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
1.3 | 4.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.3 | 1.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.3 | 2.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.3 | 1.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
1.3 | 5.2 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.3 | 1.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.3 | 3.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.3 | 1.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.3 | 3.9 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.3 | 7.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.3 | 6.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.3 | 6.4 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
1.3 | 6.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.3 | 5.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.3 | 11.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.3 | 2.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.3 | 7.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.3 | 6.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
1.2 | 5.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.2 | 5.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.2 | 2.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.2 | 3.7 | GO:0046959 | habituation(GO:0046959) |
1.2 | 3.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
1.2 | 1.2 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
1.2 | 3.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.2 | 9.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.2 | 6.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.2 | 7.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.2 | 9.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.2 | 3.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.2 | 2.4 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.2 | 4.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.2 | 4.7 | GO:0090148 | membrane fission(GO:0090148) |
1.2 | 5.8 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.2 | 4.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.2 | 3.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.2 | 3.5 | GO:0071435 | potassium ion export(GO:0071435) |
1.2 | 3.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.1 | 2.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.1 | 36.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.1 | 3.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.1 | 1.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.1 | 4.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.1 | 2.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
1.1 | 1.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.1 | 2.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.1 | 3.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.1 | 3.4 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.1 | 2.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.1 | 11.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.1 | 3.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.1 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.1 | 2.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
1.1 | 2.2 | GO:2000809 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
1.1 | 1.1 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
1.1 | 2.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.1 | 1.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.1 | 3.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.1 | 1.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.1 | 3.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.1 | 22.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.1 | 3.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.1 | 4.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.1 | 5.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.1 | 8.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.0 | 3.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 2.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.0 | 4.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.0 | 4.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.0 | 3.1 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.0 | 2.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.0 | 4.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
1.0 | 1.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.0 | 6.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.0 | 3.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 3.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.0 | 4.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.0 | 2.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.0 | 2.0 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 3.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.0 | 7.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.0 | 3.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.0 | 4.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.0 | 2.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.0 | 7.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.0 | 3.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.0 | 4.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.0 | 2.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.0 | 2.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 2.9 | GO:0015817 | histidine transport(GO:0015817) |
1.0 | 3.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 6.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.0 | 6.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.0 | 2.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.0 | 1.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.0 | 2.9 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.0 | 2.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.0 | 1.9 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
1.0 | 2.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.9 | 3.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.9 | 2.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.9 | 10.3 | GO:0060746 | parental behavior(GO:0060746) |
0.9 | 1.9 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.9 | 1.9 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.9 | 15.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.9 | 6.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.9 | 3.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.9 | 9.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.9 | 4.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.9 | 2.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.9 | 2.8 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 3.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.9 | 2.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 7.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.9 | 7.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.9 | 40.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.9 | 0.9 | GO:0033058 | directional locomotion(GO:0033058) |
0.9 | 3.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.9 | 7.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.9 | 1.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.9 | 5.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.9 | 4.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 3.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.9 | 8.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.9 | 3.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.9 | 14.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.9 | 16.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.9 | 6.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.9 | 0.9 | GO:0097480 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.9 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.9 | 0.9 | GO:0001964 | startle response(GO:0001964) |
0.9 | 2.6 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.9 | 0.9 | GO:0036314 | response to sterol(GO:0036314) |
0.9 | 4.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.9 | 0.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.9 | 4.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.9 | 2.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.9 | 0.9 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.9 | 0.9 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.8 | 0.8 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.8 | 2.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 7.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.8 | 2.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.8 | 5.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.8 | 2.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.8 | 3.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.8 | 4.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.8 | 0.8 | GO:0051665 | membrane raft localization(GO:0051665) |
0.8 | 3.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 19.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 18.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.8 | 1.6 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.8 | 1.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.8 | 0.8 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.8 | 2.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.8 | 0.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.8 | 2.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.8 | 4.0 | GO:0070723 | response to cholesterol(GO:0070723) |
0.8 | 3.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 1.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.8 | 0.8 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.8 | 2.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 1.6 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.8 | 1.6 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.8 | 4.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.8 | 2.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 1.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 0.8 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.8 | 0.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 0.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.8 | 1.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.8 | 1.6 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.8 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.8 | 2.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.8 | 4.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.8 | 6.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.8 | 2.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.8 | 0.8 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.8 | 6.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.8 | 1.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.8 | 1.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.8 | 1.5 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.8 | 12.3 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.8 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.8 | 5.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.8 | 2.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.8 | 0.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.8 | 2.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 1.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.8 | 9.9 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.8 | 2.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.8 | 3.0 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.8 | 2.3 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.8 | 1.5 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.8 | 5.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.8 | 3.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.8 | 2.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.8 | 2.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.8 | 8.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.8 | 3.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.8 | 0.8 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.8 | 3.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.8 | 4.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.7 | 5.2 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.7 | 2.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.7 | 3.7 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.7 | 3.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.7 | 3.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 13.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.7 | 1.5 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.7 | 1.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.7 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 5.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.7 | 1.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.7 | 1.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.7 | 1.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 1.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 4.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.7 | 2.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.7 | 5.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.7 | 6.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 1.5 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.7 | 13.9 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.7 | 4.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.7 | 2.9 | GO:0009414 | response to water deprivation(GO:0009414) |
0.7 | 2.9 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.7 | 2.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.7 | 0.7 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.7 | 2.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.7 | 0.7 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.7 | 2.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 31.5 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.7 | 4.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 1.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.7 | 3.6 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.7 | 0.7 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.7 | 1.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.7 | 2.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.7 | 2.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 0.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) protein K27-linked ubiquitination(GO:0044314) |
0.7 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 1.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 0.7 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.7 | 2.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.7 | 1.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.7 | 2.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.7 | 2.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.7 | 1.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.7 | 1.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.7 | 2.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.7 | 3.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.7 | 5.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.7 | 2.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.7 | 2.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 2.8 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 3.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.7 | 2.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.7 | 8.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.7 | 4.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.7 | 3.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.7 | 2.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 1.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.7 | 1.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.7 | 0.7 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.7 | 2.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.7 | 2.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 2.6 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.7 | 2.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.7 | 0.7 | GO:1902991 | positive regulation of beta-amyloid formation(GO:1902004) regulation of amyloid precursor protein catabolic process(GO:1902991) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.7 | 2.0 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.7 | 2.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.7 | 2.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.6 | 6.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 4.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.6 | 2.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 13.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.6 | 1.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 3.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.6 | 2.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 3.9 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.6 | 0.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.6 | 0.6 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.6 | 2.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.6 | 10.2 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.6 | 3.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.6 | 1.9 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.6 | 2.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.6 | 2.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.6 | 7.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.6 | 1.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.6 | 5.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.6 | 2.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 1.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.6 | 1.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.6 | 3.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.6 | 3.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.6 | 3.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.6 | 4.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.6 | 6.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.6 | 1.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 5.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.6 | 8.0 | GO:0009648 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.6 | 4.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.6 | 0.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 1.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.6 | 2.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.6 | 3.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.6 | 6.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.6 | 1.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 1.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.6 | 6.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 1.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.6 | 1.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 2.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.6 | 1.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 5.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.6 | 6.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 4.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.6 | 1.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 3.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 2.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 1.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.6 | 1.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.6 | 1.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.6 | 3.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.6 | 2.4 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.6 | 9.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.6 | 0.6 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.6 | 4.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.6 | 3.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 2.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.6 | 2.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 0.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 2.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 1.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.6 | 2.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 4.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 19.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.6 | 7.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.6 | 0.6 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.6 | 1.7 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.6 | 3.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 0.6 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.6 | 7.5 | GO:0061014 | regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
0.6 | 1.7 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.6 | 2.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 25.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.6 | 1.7 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.6 | 5.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 1.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 1.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.6 | 1.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 1.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.6 | 3.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 7.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 0.6 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.6 | 1.7 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 2.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.6 | 3.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.6 | 1.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.6 | 0.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.6 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.6 | 2.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 3.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.6 | 1.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.6 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.6 | 1.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.5 | 4.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 1.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.5 | 1.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.5 | 1.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.5 | 3.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.5 | 2.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 1.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 1.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 4.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.5 | 3.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.5 | 1.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.5 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 2.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 1.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.5 | 1.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.5 | 3.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 5.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.5 | 22.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.5 | 1.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.5 | 1.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.5 | 13.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.5 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 0.5 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.5 | 2.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.5 | 1.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 1.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 1.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 2.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 1.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 3.6 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.5 | 3.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 2.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 2.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 1.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 1.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.5 | 3.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 0.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 4.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 7.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 0.5 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.5 | 3.0 | GO:0030238 | male sex determination(GO:0030238) |
0.5 | 2.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.5 | 2.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 3.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.5 | 1.0 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.5 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 1.0 | GO:0097484 | dendrite extension(GO:0097484) |
0.5 | 0.5 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.5 | 1.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.5 | 0.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.5 | 1.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.5 | 8.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.5 | 3.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 3.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.5 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.5 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.5 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 1.0 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.5 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 2.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.5 | 2.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 1.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.5 | 1.0 | GO:0006997 | nucleus organization(GO:0006997) |
0.5 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.0 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 1.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 2.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 1.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.5 | 2.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 4.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 4.8 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.5 | 9.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 1.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.5 | 3.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 1.0 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.5 | 1.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 2.9 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.5 | 0.5 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.5 | 5.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 1.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.5 | 2.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 4.3 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.5 | 1.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 0.9 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 4.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 7.6 | GO:0001662 | behavioral fear response(GO:0001662) |
0.5 | 0.5 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.5 | 3.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.5 | 0.9 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.5 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 2.4 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.5 | 2.8 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.5 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.5 | 3.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.5 | 2.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 6.5 | GO:0097009 | energy homeostasis(GO:0097009) |
0.5 | 1.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 2.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 1.4 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.5 | 2.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.5 | 4.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 6.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.5 | 7.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 5.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 1.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.5 | 4.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 0.9 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.5 | 0.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 1.8 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.5 | 0.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.5 | 1.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 2.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 4.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.5 | 2.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 0.5 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.5 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.5 | 0.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 9.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.4 | 0.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 1.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 1.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 0.9 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.4 | 3.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 0.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 0.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 3.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.4 | 4.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 2.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.9 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.4 | 1.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 5.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.4 | 1.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 2.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 0.9 | GO:0015793 | glycerol transport(GO:0015793) |
0.4 | 2.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 3.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.4 | 7.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 0.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 4.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 3.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 1.3 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 1.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 0.4 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.4 | 0.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.4 | 0.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 0.4 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.4 | 1.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.4 | 0.9 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.4 | 0.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 2.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 1.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 1.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 8.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 3.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.4 | 8.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 2.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 8.4 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.4 | 34.1 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.4 | 2.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.4 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 2.5 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.4 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 1.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.4 | 4.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 7.9 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.4 | 53.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.4 | 8.7 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.4 | 1.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 1.2 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.4 | 2.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.4 | 3.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.4 | 2.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.4 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 1.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.4 | 0.8 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.4 | 3.2 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.4 | 0.8 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 0.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 4.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 0.4 | GO:0031620 | regulation of fever generation(GO:0031620) TNFSF11-mediated signaling pathway(GO:0071847) |
0.4 | 0.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 6.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.4 | 1.2 | GO:0060078 | regulation of postsynaptic membrane potential(GO:0060078) |
0.4 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.4 | 0.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 0.8 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.4 | 0.4 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.4 | 0.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 2.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 3.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 1.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.4 | 1.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 16.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.4 | 1.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.4 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 0.8 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 2.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 2.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 2.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.4 | 3.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 1.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 1.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.4 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 5.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.4 | 4.3 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 3.5 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.4 | 3.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 8.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 1.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 1.6 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 3.5 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.4 | 0.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.4 | 0.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 0.8 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 0.8 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.4 | 18.1 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
0.4 | 0.8 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.4 | 1.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 1.5 | GO:0070922 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) |
0.4 | 3.8 | GO:0021591 | ventricular system development(GO:0021591) |
0.4 | 11.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.4 | 13.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.4 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 3.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.4 | 1.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.4 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 1.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 0.8 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.4 | 2.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 0.8 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 1.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.4 | 1.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 2.2 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.4 | 2.6 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 7.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.4 | 1.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.4 | 0.7 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 1.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.4 | 1.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 2.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 2.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 1.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.4 | 1.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 2.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 0.4 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.4 | 0.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 2.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 5.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.4 | 2.5 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.4 | 1.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 1.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.7 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 2.4 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.3 | 0.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 7.9 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.3 | 0.7 | GO:0003157 | endocardium development(GO:0003157) |
0.3 | 1.0 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 7.2 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.3 | 5.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 1.0 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.3 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.3 | 3.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.3 | 2.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 0.7 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 1.7 | GO:0070741 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.3 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 2.3 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 1.3 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 3.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.3 | 1.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 1.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 3.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 1.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.3 | 4.6 | GO:0031103 | axon regeneration(GO:0031103) |
0.3 | 0.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.3 | 1.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 3.2 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.3 | 2.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 0.6 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.3 | 2.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 5.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 2.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 2.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.3 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 1.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 1.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.3 | 1.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.3 | 0.6 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.3 | 0.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.3 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.3 | 0.3 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 2.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.3 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 1.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 14.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 1.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 0.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.6 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.3 | 1.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.9 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 1.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 1.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.3 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 2.1 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.3 | 2.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 2.7 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.3 | 1.8 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 0.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 0.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 7.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.6 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 3.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.6 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 5.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 0.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 2.9 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.3 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 1.2 | GO:2000278 | regulation of DNA biosynthetic process(GO:2000278) |
0.3 | 0.3 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.3 | 1.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 1.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 0.6 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 0.3 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.3 | 1.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.3 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.3 | 0.6 | GO:1903335 | regulation of vacuolar transport(GO:1903335) |
0.3 | 2.9 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.3 | 1.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.3 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.3 | 2.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 10.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 0.3 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 0.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 5.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 0.3 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.3 | 2.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.3 | 0.3 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.3 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 2.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 3.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 1.7 | GO:0014047 | glutamate secretion(GO:0014047) |
0.3 | 0.8 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 0.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 2.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 0.3 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.3 | 0.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 1.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 1.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 4.6 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.3 | 1.1 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 2.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.5 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 0.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.3 | 0.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 0.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 1.1 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 9.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 0.8 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 10.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 3.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 0.3 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.3 | 0.5 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.3 | 1.0 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 1.3 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.3 | 1.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 1.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 0.8 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 2.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 5.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.3 | 3.1 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.3 | 4.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 2.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 2.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.3 | 1.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 2.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.7 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 2.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 1.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 1.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 1.2 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.2 | 1.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 1.2 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.2 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.2 | 7.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 29.2 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.2 | 0.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 3.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 1.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.2 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.2 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 4.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.9 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.2 | 0.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 0.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 0.9 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 6.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 6.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.9 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
0.2 | 2.0 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.2 | 0.5 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 2.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.5 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 1.6 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.2 | 2.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 15.5 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 0.4 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.2 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.2 | 1.8 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.2 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 2.0 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.2 | 2.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.4 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.2 | 0.7 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.7 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.4 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.2 | 2.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.2 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 0.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.7 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 0.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.4 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.2 | 0.8 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 0.8 | GO:0016233 | telomere capping(GO:0016233) |
0.2 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 3.6 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.2 | 3.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 3.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) histone mRNA metabolic process(GO:0008334) |
0.2 | 0.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 4.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 1.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.8 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 1.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 0.8 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.2 | 0.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.2 | 0.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.8 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 0.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.2 | 3.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 1.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 1.0 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 2.0 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 1.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 1.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 7.2 | GO:0001678 | cellular glucose homeostasis(GO:0001678) |
0.2 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 1.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 3.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.4 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 0.8 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.2 | 2.3 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.2 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 30.9 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 1.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.8 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 1.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.4 | GO:2001212 | regulation of vasculogenesis(GO:2001212) positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.2 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.2 | 2.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 0.2 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.4 | GO:0019081 | viral translation(GO:0019081) |
0.2 | 1.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.6 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.2 | 0.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 1.7 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 1.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.2 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.2 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 1.5 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.7 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 1.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.2 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.2 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.2 | 0.4 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.2 | 1.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.4 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.2 | 0.7 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 1.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.2 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 6.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.3 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 1.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 1.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 5.7 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 1.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 5.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 2.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 1.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 1.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 4.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 1.9 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.2 | 2.2 | GO:0036503 | ERAD pathway(GO:0036503) |
0.2 | 0.9 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.2 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.2 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.9 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.2 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.5 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.2 | 0.5 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 1.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 1.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 1.4 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.2 | 0.6 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.2 | 0.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 1.4 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 1.0 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 0.6 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.1 | 2.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.3 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 8.9 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.6 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.4 | GO:0007098 | centrosome cycle(GO:0007098) |
0.1 | 0.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 5.9 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 1.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.6 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 1.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.7 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.3 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 6.1 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.1 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.4 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.5 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 1.6 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 4.8 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 0.3 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.7 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.1 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 9.3 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.9 | GO:0098732 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.1 | 0.3 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.4 | GO:0006323 | DNA packaging(GO:0006323) |
0.1 | 0.1 | GO:0019076 | viral release from host cell(GO:0019076) |
0.1 | 0.7 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.1 | 1.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 1.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 2.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.4 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 1.7 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 1.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.5 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.6 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 3.6 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 1.0 | GO:0051668 | localization within membrane(GO:0051668) |
0.1 | 1.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 1.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.1 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.4 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.8 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.8 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 3.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 1.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 1.4 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 20.3 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.2 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.7 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 1.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 2.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 1.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.9 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
0.1 | 0.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.1 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.1 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.8 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.4 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) |
0.1 | 0.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 3.4 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 1.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.3 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 1.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.3 | GO:0009261 | ribonucleotide catabolic process(GO:0009261) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) aromatic amino acid family catabolic process(GO:0009074) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 1.0 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 1.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 2.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.7 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 1.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.2 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.1 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 1.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.2 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.8 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.3 | GO:0018065 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.1 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.0 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.1 | 7.8 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.1 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.1 | 0.1 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 1.2 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 2.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
0.1 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.8 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.4 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 5.1 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.1 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.5 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 1.0 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 3.6 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.4 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.1 | 0.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.6 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.1 | 0.1 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 2.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.6 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.6 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.4 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.3 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.1 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
0.1 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.6 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.3 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.1 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.1 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.0 | 0.0 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.1 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.0 | 1.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.3 | GO:0045471 | response to ethanol(GO:0045471) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.0 | 2.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.7 | GO:0016311 | dephosphorylation(GO:0016311) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 1.2 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.6 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.0 | 0.9 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 6.5 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.3 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.0 | 0.1 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.3 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 1.0 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 1.1 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.2 | GO:0044772 | mitotic cell cycle phase transition(GO:0044772) |
0.0 | 0.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.5 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 0.3 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.0 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.0 | 0.8 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.0 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.0 | 0.0 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.0 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 11.7 | GO:0072487 | MSL complex(GO:0072487) |
2.8 | 16.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.6 | 36.1 | GO:0071565 | nBAF complex(GO:0071565) |
2.5 | 12.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.4 | 7.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.4 | 7.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.3 | 6.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.2 | 6.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
2.1 | 6.4 | GO:0043511 | inhibin complex(GO:0043511) |
2.0 | 12.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.0 | 8.1 | GO:0005667 | transcription factor complex(GO:0005667) |
2.0 | 15.8 | GO:0001650 | fibrillar center(GO:0001650) |
1.9 | 5.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.9 | 7.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.8 | 7.3 | GO:0005642 | annulate lamellae(GO:0005642) |
1.8 | 5.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.8 | 14.3 | GO:0090544 | BAF-type complex(GO:0090544) |
1.8 | 1.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.8 | 7.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.7 | 17.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.7 | 5.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.6 | 4.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.6 | 4.7 | GO:0031417 | NatC complex(GO:0031417) |
1.6 | 64.3 | GO:0031519 | PcG protein complex(GO:0031519) |
1.5 | 6.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.5 | 10.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 15.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.5 | 8.9 | GO:0044327 | dendritic spine head(GO:0044327) |
1.5 | 7.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.5 | 13.2 | GO:0000124 | SAGA complex(GO:0000124) |
1.5 | 5.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.4 | 5.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.4 | 8.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.4 | 1.4 | GO:0098793 | presynapse(GO:0098793) |
1.4 | 5.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.4 | 19.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.3 | 4.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.3 | 4.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.3 | 22.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.3 | 11.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.3 | 5.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.2 | 4.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.2 | 4.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.2 | 10.5 | GO:0016342 | catenin complex(GO:0016342) |
1.2 | 28.8 | GO:0032590 | dendrite membrane(GO:0032590) |
1.2 | 5.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.1 | 6.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.1 | 3.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.1 | 1.1 | GO:0000812 | Swr1 complex(GO:0000812) |
1.1 | 3.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.1 | 5.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 7.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 3.1 | GO:0048179 | activin receptor complex(GO:0048179) |
1.0 | 5.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.0 | 4.0 | GO:0005883 | neurofilament(GO:0005883) |
1.0 | 10.0 | GO:0016580 | Sin3 complex(GO:0016580) |
1.0 | 3.0 | GO:0097427 | microtubule bundle(GO:0097427) |
1.0 | 5.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 25.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.0 | 1.0 | GO:0097440 | apical dendrite(GO:0097440) |
1.0 | 10.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.0 | 4.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.0 | 2.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.0 | 7.7 | GO:0071437 | invadopodium(GO:0071437) |
1.0 | 52.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
1.0 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
1.0 | 6.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.0 | 8.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.9 | 13.3 | GO:0010369 | chromocenter(GO:0010369) |
0.9 | 5.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.9 | 34.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.9 | 3.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.9 | 2.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.9 | 3.7 | GO:0000938 | GARP complex(GO:0000938) |
0.9 | 38.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.9 | 2.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 8.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.9 | 15.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.9 | 40.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 2.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.9 | 12.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.9 | 2.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 2.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 6.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 2.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.8 | 16.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.8 | 4.2 | GO:0089701 | U2AF(GO:0089701) |
0.8 | 3.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.8 | 7.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.8 | 0.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.8 | 3.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.8 | 2.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.8 | 3.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 12.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 8.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.8 | 2.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.8 | 6.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 14.6 | GO:0030904 | retromer complex(GO:0030904) |
0.8 | 16.0 | GO:0000786 | nucleosome(GO:0000786) |
0.8 | 2.3 | GO:0044308 | axonal spine(GO:0044308) |
0.8 | 4.5 | GO:0031415 | NatA complex(GO:0031415) |
0.7 | 2.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.7 | 13.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 3.7 | GO:0051286 | cell tip(GO:0051286) |
0.7 | 4.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.7 | 9.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.7 | 0.7 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.7 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.7 | 2.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 3.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.7 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 31.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.7 | 4.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.7 | 1.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.7 | 4.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.7 | 6.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.7 | 6.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 2.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 1.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.7 | 20.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 5.3 | GO:0097346 | INO80-type complex(GO:0097346) |
0.7 | 5.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.7 | 15.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.7 | 4.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.7 | 5.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.6 | 39.2 | GO:0016605 | PML body(GO:0016605) |
0.6 | 3.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.6 | 2.5 | GO:0030689 | Noc complex(GO:0030689) |
0.6 | 71.8 | GO:0030426 | growth cone(GO:0030426) |
0.6 | 2.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.6 | 4.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 2.4 | GO:0032021 | NELF complex(GO:0032021) |
0.6 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 1.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 2.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 13.7 | GO:0012505 | endomembrane system(GO:0012505) |
0.6 | 11.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 1.7 | GO:0036396 | MIS complex(GO:0036396) |
0.6 | 2.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.6 | 2.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.6 | 6.2 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 2.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 1.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.6 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 1.1 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 4.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 3.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 65.9 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.6 | 9.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 14.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 4.4 | GO:0001741 | XY body(GO:0001741) |
0.5 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 1.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.5 | 2.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 6.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 3.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 6.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 2.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.5 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 6.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 1.6 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 6.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.5 | 3.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.5 | 1.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 8.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.5 | 28.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 2.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 5.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 17.1 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 1.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 8.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 1.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 4.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 1.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 2.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 19.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.5 | 3.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 1.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 2.3 | GO:1990752 | microtubule end(GO:1990752) |
0.5 | 11.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.5 | 2.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 85.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.4 | 3.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 16.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 7.6 | GO:0034399 | nuclear periphery(GO:0034399) |
0.4 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 0.9 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 6.0 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 6.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 4.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 2.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 1.3 | GO:0097433 | dense body(GO:0097433) |
0.4 | 8.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 3.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 6.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 6.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 3.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 0.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 2.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 1.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 3.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 6.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 2.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 1.6 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 5.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 11.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 7.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 1.5 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 1.1 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 0.4 | GO:1903349 | omegasome membrane(GO:1903349) |
0.4 | 0.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 8.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 2.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 2.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 4.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 2.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 18.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 3.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 2.2 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 2.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 2.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 1.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 14.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 4.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 65.5 | GO:0000785 | chromatin(GO:0000785) |
0.4 | 3.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 417.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 4.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 1.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 3.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 1.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 2.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 10.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 26.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 3.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 2.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 3.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 2.0 | GO:0000801 | central element(GO:0000801) |
0.3 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 1.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 7.5 | GO:0005844 | polysome(GO:0005844) |
0.3 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 5.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 1.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 1.6 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 1.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 4.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 5.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 12.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 1.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 4.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 2.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 2.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 13.7 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 4.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 4.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 14.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.2 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.3 | 1.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 5.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 5.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 2.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 11.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 1.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 5.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 2.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 3.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 91.5 | GO:0005768 | endosome(GO:0005768) |
0.3 | 1.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 0.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 1.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 2.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 2.5 | GO:0098687 | chromosomal region(GO:0098687) |
0.3 | 9.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 16.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 1.2 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.2 | 49.7 | GO:0044297 | cell body(GO:0044297) |
0.2 | 37.0 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.7 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 704.8 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.2 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.2 | 10.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 1.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 5.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 1.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 26.9 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 0.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 3.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 5.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 3.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 23.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 3.3 | GO:0044438 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.2 | 3.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 1.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 70.8 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.2 | 0.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 2.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 2.3 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.2 | 0.8 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 4.5 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.4 | GO:0012506 | vesicle membrane(GO:0012506) |
0.2 | 0.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 2.8 | GO:0045202 | synapse(GO:0045202) |
0.2 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.0 | GO:0005903 | brush border(GO:0005903) |
0.2 | 4.1 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.2 | 2.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 0.7 | GO:0031090 | organelle membrane(GO:0031090) |
0.2 | 22.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 9.3 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 0.9 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 28.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 1.2 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 46.9 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.1 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.9 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 11.9 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.1 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 9.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 223.1 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.2 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 3.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 2.1 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.0 | 125.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 2.3 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 3.6 | GO:0016020 | membrane(GO:0016020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.4 | GO:0050692 | DBD domain binding(GO:0050692) |
3.6 | 3.6 | GO:0038191 | neuropilin binding(GO:0038191) |
3.6 | 10.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.5 | 10.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
3.4 | 10.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.2 | 12.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
3.1 | 15.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.7 | 8.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.6 | 10.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.6 | 7.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.5 | 10.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
2.3 | 6.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.3 | 11.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.2 | 6.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.2 | 4.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.2 | 6.7 | GO:1990188 | euchromatin binding(GO:1990188) |
2.2 | 8.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.2 | 17.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.2 | 6.5 | GO:0004359 | glutaminase activity(GO:0004359) |
2.1 | 6.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.0 | 10.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.9 | 25.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.9 | 7.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.9 | 17.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.8 | 5.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.8 | 7.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.8 | 5.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.8 | 5.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.7 | 5.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.7 | 15.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.7 | 5.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.7 | 5.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.7 | 8.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.7 | 1.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.7 | 5.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.6 | 9.8 | GO:0043426 | MRF binding(GO:0043426) |
1.6 | 9.6 | GO:0030274 | LIM domain binding(GO:0030274) |
1.5 | 4.6 | GO:0097016 | L27 domain binding(GO:0097016) |
1.5 | 4.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.5 | 4.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.5 | 5.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.5 | 4.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.4 | 8.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.4 | 5.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.4 | 8.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.4 | 11.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.4 | 11.0 | GO:0034046 | poly(G) binding(GO:0034046) |
1.3 | 9.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.3 | 14.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.3 | 2.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.3 | 18.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.3 | 7.9 | GO:0000182 | rDNA binding(GO:0000182) |
1.3 | 38.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.3 | 14.3 | GO:0048156 | tau protein binding(GO:0048156) |
1.3 | 5.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.3 | 3.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.3 | 2.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.3 | 6.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 3.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.3 | 28.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.3 | 38.8 | GO:0031491 | nucleosome binding(GO:0031491) |
1.2 | 13.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 8.5 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
1.2 | 2.4 | GO:0050693 | LBD domain binding(GO:0050693) |
1.2 | 3.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.2 | 22.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.2 | 3.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 3.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.2 | 13.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.2 | 3.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.2 | 3.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.2 | 8.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.2 | 5.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.2 | 4.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.2 | 3.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.2 | 35.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.2 | 3.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.2 | 5.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.1 | 8.0 | GO:0034711 | inhibin binding(GO:0034711) |
1.1 | 4.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.1 | 4.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 1.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.1 | 13.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.1 | 31.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.1 | 4.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.1 | 1.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.1 | 17.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
1.1 | 2.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.1 | 1.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.1 | 6.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 6.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.0 | 4.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.0 | 4.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.0 | 2.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.0 | 6.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.0 | 5.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.0 | 6.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.0 | 3.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.0 | 3.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 3.0 | GO:0030911 | TPR domain binding(GO:0030911) |
1.0 | 9.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.0 | 3.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 3.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 3.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.0 | 5.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.0 | 8.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.0 | 6.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 6.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.0 | 2.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 1.9 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 1.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.0 | 2.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.0 | 4.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 14.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.9 | 3.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 6.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 3.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.9 | 2.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.9 | 6.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 2.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 7.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.9 | 1.8 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.9 | 7.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.9 | 14.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.9 | 2.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 2.7 | GO:2001070 | starch binding(GO:2001070) |
0.9 | 13.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.9 | 18.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.9 | 30.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.9 | 19.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.9 | 2.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 8.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 7.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.9 | 1.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.9 | 2.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 1.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.9 | 5.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 2.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.8 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 2.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 3.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.8 | 2.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.8 | 2.5 | GO:0019961 | interferon binding(GO:0019961) |
0.8 | 2.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.8 | 2.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.8 | 2.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.8 | 3.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.8 | 2.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 3.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.8 | 3.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 5.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.8 | 8.8 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 7.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.8 | 4.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.8 | 7.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.8 | 23.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.8 | 14.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 13.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.8 | 2.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.8 | 10.1 | GO:0031005 | filamin binding(GO:0031005) |
0.8 | 3.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.8 | 6.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.8 | 2.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.8 | 3.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 5.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.8 | 6.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.7 | 2.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 6.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.7 | 6.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.7 | 3.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 9.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 2.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.7 | 19.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.7 | 4.4 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 17.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 5.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 17.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.7 | 1.4 | GO:0033265 | choline binding(GO:0033265) |
0.7 | 23.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.7 | 2.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.7 | 4.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.7 | 17.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.7 | 2.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 6.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 5.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 3.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 4.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 3.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 11.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 2.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 10.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.7 | 3.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 39.5 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 15.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 14.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 2.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.7 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.7 | 2.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.7 | 0.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.6 | 3.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 1.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.6 | 16.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.6 | 5.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.6 | 23.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.6 | 2.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.6 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 2.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 3.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 1.9 | GO:0019002 | GMP binding(GO:0019002) |
0.6 | 1.9 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 1.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 1.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.6 | 5.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 1.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.6 | 3.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 3.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 6.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 23.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.6 | 8.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.6 | 4.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.6 | 1.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.6 | 1.8 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.6 | 12.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.6 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 67.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.6 | 4.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 6.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 16.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 5.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.6 | 4.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 1.7 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.6 | 5.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.6 | 2.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 7.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.6 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 1.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.6 | 1.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 5.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.6 | 3.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.5 | 3.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 6.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 1.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 25.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 0.5 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.5 | 4.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 2.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.5 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 6.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 3.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 2.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 10.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 2.6 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.5 | 2.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 1.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 3.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 1.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 5.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 3.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 1.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 3.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.5 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 3.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 7.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.5 | 28.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.5 | 29.2 | GO:0019207 | kinase regulator activity(GO:0019207) |
0.5 | 3.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 1.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 1.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 1.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 2.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 8.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.5 | 0.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 35.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.5 | 1.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 4.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 0.5 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.5 | 5.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.5 | 4.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.5 | 2.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 7.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 0.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.5 | 1.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 3.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 1.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 4.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 13.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.5 | 7.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 11.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.5 | 4.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 26.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.5 | 11.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.5 | 90.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 1.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 1.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.5 | 9.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 4.0 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 42.0 | GO:0003729 | mRNA binding(GO:0003729) |
0.4 | 1.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 4.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 0.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.4 | 0.4 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.4 | 1.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 1.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 3.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 1.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.4 | 1.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 2.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 1.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 1.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 0.8 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 0.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 19.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 7.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 3.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 4.9 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 66.8 | GO:0043774 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.4 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 17.9 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 1.6 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.4 | 1.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 0.4 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.4 | 6.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 4.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 3.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 19.3 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 2.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 1.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 0.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 1.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 1.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 3.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 3.1 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 1.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 6.2 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 1.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 7.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 2.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 3.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 0.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 1.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 2.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.4 | 9.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 3.4 | GO:0046977 | TAP binding(GO:0046977) |
0.4 | 14.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.4 | 8.2 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.4 | 45.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.4 | 1.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 1.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 2.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 2.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 4.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 1.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 14.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.4 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 5.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 6.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.4 | 12.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 2.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 7.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 33.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.4 | 3.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 2.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 1.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 10.7 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 2.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 4.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 3.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.3 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 7.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 1.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 2.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 1.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 3.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 3.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 2.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 2.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 1.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 24.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.3 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 3.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 6.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 4.1 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.3 | 1.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 1.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.3 | 1.3 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.6 | GO:0004525 | ribonuclease III activity(GO:0004525) bidentate ribonuclease III activity(GO:0016443) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 6.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 1.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 13.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 0.6 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.3 | 0.9 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 201.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.3 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 2.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 3.3 | GO:0034876 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.3 | 5.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 8.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 8.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 7.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.3 | 42.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.3 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 1.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 2.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 7.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 19.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 8.2 | GO:0008134 | transcription factor binding(GO:0008134) |
0.3 | 3.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 9.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.3 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 14.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.3 | 5.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 3.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 6.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 10.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 8.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 4.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 2.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 12.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 1.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 2.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 8.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 1.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 2.7 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 12.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 52.5 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 1.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 1.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 3.9 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 3.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 4.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 3.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 1.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 9.1 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 2.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.6 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 1.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 3.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.2 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 1.2 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.4 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 1.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 1.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.4 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 5.5 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.2 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 24.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 21.9 | GO:0019900 | kinase binding(GO:0019900) |
0.2 | 1.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 66.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.2 | 1.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 3.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 3.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.2 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.2 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 1.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 2.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 2.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 1.6 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.2 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 1.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 2.2 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 1.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 2.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 2.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.3 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.1 | 2.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.3 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 96.5 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 3.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 2.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 8.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.4 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0016401 | acyl-CoA oxidase activity(GO:0003997) palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 0.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 1.9 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 3.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 1.0 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 10.1 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 11.0 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 2.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.8 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 10.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 6.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.3 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 1.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.7 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 3.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 2.8 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 3.4 | GO:0005543 | phospholipid binding(GO:0005543) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 12.4 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 2.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 1.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 6.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.7 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.4 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 2.2 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.1 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 1.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 7.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.4 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 1.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.8 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.1 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 1.1 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.0 | 0.1 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.5 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 3.1 | GO:0019899 | enzyme binding(GO:0019899) |
0.0 | 0.0 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.3 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 0.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 27.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.4 | 34.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.4 | 39.9 | PID IGF1 PATHWAY | IGF1 pathway |
1.3 | 3.8 | PID SHP2 PATHWAY | SHP2 signaling |
1.2 | 15.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.2 | 2.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.2 | 34.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.1 | 24.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.1 | 11.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 25.2 | PID REELIN PATHWAY | Reelin signaling pathway |
1.1 | 50.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.1 | 12.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.0 | 20.3 | PID RAS PATHWAY | Regulation of Ras family activation |
1.0 | 5.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.0 | 13.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.0 | 29.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 2.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.9 | 2.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.9 | 28.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.9 | 8.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.9 | 45.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.9 | 1.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 11.8 | PID MYC PATHWAY | C-MYC pathway |
0.8 | 29.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.8 | 12.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.8 | 22.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.8 | 9.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.8 | 7.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.8 | 6.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 3.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 9.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.8 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.7 | 10.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 21.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 7.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.7 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 4.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 3.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 4.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.7 | 6.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.7 | 1.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 10.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.7 | 21.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.7 | 12.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 6.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 8.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.6 | 17.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.6 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 7.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 12.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 5.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 3.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 6.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 9.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 7.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 7.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 6.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 11.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 9.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 7.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 16.6 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 2.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 18.5 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 6.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 8.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 1.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 4.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 5.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.5 | 2.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 9.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 11.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 1.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 7.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 3.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 8.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 2.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 3.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 7.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 4.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 2.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 2.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 1.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 1.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 3.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 9.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 4.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 10.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 13.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 2.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 1.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 5.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 0.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 2.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 1.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 3.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 7.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 3.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 4.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 4.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 1.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 1.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 23.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 2.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 2.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 18.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.2 | 2.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
2.0 | 22.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.8 | 31.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.7 | 3.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.7 | 25.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.7 | 13.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.6 | 11.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.4 | 23.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.4 | 4.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.4 | 15.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.3 | 17.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.3 | 12.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.2 | 1.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.2 | 45.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.2 | 9.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.2 | 9.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.2 | 4.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.2 | 9.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.2 | 9.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.1 | 17.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.0 | 15.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.0 | 17.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.0 | 13.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.0 | 3.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.0 | 16.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.0 | 1.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
1.0 | 3.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.0 | 1.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.9 | 10.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.9 | 11.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.9 | 4.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.9 | 33.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.9 | 10.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 8.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 7.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.9 | 14.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.9 | 11.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.9 | 13.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 0.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.8 | 7.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 10.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 8.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.8 | 15.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.8 | 10.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.8 | 9.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.8 | 5.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.8 | 13.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 6.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.8 | 12.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 6.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 12.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.7 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.7 | 3.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.7 | 2.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.7 | 5.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.7 | 4.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.7 | 2.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.7 | 19.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.7 | 12.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 9.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 5.4 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.7 | 5.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 3.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 3.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 3.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 9.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 3.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 10.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 4.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.6 | 14.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.6 | 2.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.6 | 1.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 8.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 12.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.6 | 6.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 11.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 6.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 17.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.6 | 5.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 4.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 7.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 27.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 11.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 20.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 17.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.5 | 0.5 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.5 | 1.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 1.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 7.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 2.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 1.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 6.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 7.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 7.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 9.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.5 | 13.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 2.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 9.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 2.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 3.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 3.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 2.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 7.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 6.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 2.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 7.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 74.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 2.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 5.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 7.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 15.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 2.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 16.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 4.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 3.5 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.4 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 17.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 0.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.4 | 12.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 2.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 2.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 2.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 2.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 3.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 4.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 9.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 4.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 23.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 8.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 2.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 7.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 5.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 4.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 4.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 2.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 4.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.3 | 3.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.3 | 2.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 1.3 | REACTOME S PHASE | Genes involved in S Phase |
0.3 | 5.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 7.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 3.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 0.9 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.3 | 24.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 5.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 6.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 7.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 16.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 0.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 4.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 4.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 1.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 0.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.3 | 2.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 2.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 4.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 3.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 2.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 3.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 1.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 8.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 6.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 3.7 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 2.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 4.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 5.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.2 | 9.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 8.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 9.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 2.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 3.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.6 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 3.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 2.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 7.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 4.9 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 3.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 2.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 3.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 11.7 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 9.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 4.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 4.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 2.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 3.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.5 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.2 | 1.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 5.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 1.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 17.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 5.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.1 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
0.1 | 1.3 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 0.3 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 3.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 7.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.6 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 2.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 4.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.1 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 1.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |